CUTANEOUS MUCORMYCOSIS

This adverse event was reported 184 times

CUTANEOUS MUCORMYCOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DEXRAZOXANE FOR INJECTION 5 0.0053
1 ANIDULAFUNGIN 5 0.0031
2 ATOVAQUONE 21 0.0025
3 IDECABTAGENE VICLEUCEL 2 0.0016
4 VALGANCICLOVIR 27 0.0014
5 PURIXAN 1 0.0013
6 PHYTONADIONE 11 0.0013
7 REMDESIVIR 15 0.0011
8 TREOSULFAN 3 0.0011
9 AMPHOTERICIN B 13 0.0010
See all drugs enriched for association with CUTANEOUS MUCORMYCOSIS